Cargando…

The cancer theory of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) remains a mysterious killer that, like cancer, is characterized by tremendous complexity. PAH development occurs under sustained and persistent environmental stress, such as inflammation, shear stress, pseudo-hypoxia, and more. After inducing an initial death of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boucherat, Olivier, Vitry, Geraldine, Trinh, Isabelle, Paulin, Roxane, Provencher, Steeve, Bonnet, Sebastien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5467931/ https://www.ncbi.nlm.nih.gov/pubmed/28597757 http://dx.doi.org/10.1177/2045893217701438

Ejemplares similares

DNA Damage and Pulmonary Hypertension
por: Ranchoux, Benoît, et al.
Publicado: (2016)

Dual ET(A)/ET(B) blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension
por: Nadeau, Valerie, et al.
Publicado: (2017)

HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension
por: Boucherat, Olivier, et al.
Publicado: (2017)

Signal transduction in the development of pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2013)

Pim-1: A new biomarker in pulmonary arterial hypertension
por: Renard, Sébastien, et al.
Publicado: (2013)

Fetal Gene Reactivation in Pulmonary Arterial Hypertension: GOOD, BAD, or BOTH?
por: Lemay, Sarah-Eve, et al.
Publicado: (2021)

Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms
por: Malenfant, Simon, et al.
Publicado: (2021)

Preclinical Investigation of Trifluoperazine as a Novel Therapeutic Agent for the Treatment of Pulmonary Arterial Hypertension
por: Grobs, Yann, et al.
Publicado: (2021)

PARP1-PKM2 Axis Mediates Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
por: Shimauchi, Tsukasa, et al.
Publicado: (2022)

STAT3 signaling in pulmonary arterial hypertension
por: Paulin, Roxane, et al.
Publicado: (2012)

Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges
por: Lajoie, Annie-Christine, et al.
Publicado: (2017)

Reply to Ning et al.: More Insights into the Association between RVX-208 and Pulmonary Arterial Hypertension
por: Provencher, Steeve, et al.
Publicado: (2020)

Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension
por: Courboulin, Audrey, et al.
Publicado: (2011)

Involvement of PFKFB3 in Pulmonary Arterial Hypertension Pathogenesis. Is It All about Glycolysis?
por: Bonnet, Sebastien, et al.
Publicado: (2019)

Role for miR-204 in human pulmonary arterial hypertension
por: Courboulin, Audrey, et al.
Publicado: (2011)

Interpreting risk reduction in clinical trials for pulmonary arterial hypertension
por: Lajoie, Annie C., et al.
Publicado: (2018)

Reply to Chen et al.: BET Signaling: A Novel Therapeutic Target for Pulmonary Hypertension?
por: Provencher, Steeve, et al.
Publicado: (2020)

Continuous reduction in cerebral oxygenation during endurance exercise in patients with pulmonary arterial hypertension
por: Malenfant, Simon, et al.
Publicado: (2020)

Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension Etiology
por: Meloche, Jolyane, et al.
Publicado: (2013)

Alternatives to the Six-Minute Walk Test in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2014)

Implication of EZH2 in the Pro-Proliferative and Apoptosis-Resistant Phenotype of Pulmonary Artery Smooth Muscle Cells in PAH: A Transcriptomic and Proteomic Approach
por: Habbout, Karima, et al.
Publicado: (2021)

Compromised Cerebrovascular Regulation and Cerebral Oxygenation in Pulmonary Arterial Hypertension
por: Malenfant, Simon, et al.
Publicado: (2017)

COVID-19 and the pulmonary vasculature
por: Provencher, Steeve, et al.
Publicado: (2020)

Identity crisis in pulmonary arterial hypertension
por: Ruffenach, G., et al.
Publicado: (2017)

Assessment of Daily Life Physical Activities in Pulmonary Arterial Hypertension
por: Mainguy, Vincent, et al.
Publicado: (2011)

Neutrophil-Lymphocyte Ratio as an Independent Predictor of Survival in Pulmonary Arterial Hypertension: An Exploratory Study
por: Jutras-Beaudoin, Naomie, et al.
Publicado: (2021)

Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension
por: Samson, Nolwenn, et al.
Publicado: (2017)

Quality of Life, Safety and Efficacy Profile of Thermostable Flolan in Pulmonary Arterial Hypertension
por: Provencher, Steeve, et al.
Publicado: (2015)

Pulmonary hypertension-targeted therapies in heart failure: A systematic review and meta-analysis
por: Guay, Charles-Antoine, et al.
Publicado: (2018)

Reply to Piquereau and Perros and to Pullamsetti and de Jesus Perez
por: Kurakula, Kondababu, et al.
Publicado: (2019)

2251: An estrogen receptor α (ERα)-BMPR2-apelin axis mediates 17β-estradiol’s protective effects on right ventricular function in experimental pulmonary hypertension (PH)
por: Lee Frump, Andrea, et al.
Publicado: (2018)

Right Ventricular Dysfunction in Pulmonary Hypertension: Is Resistin a Promising Target?
por: Lemay, Sarah‐Eve, et al.
Publicado: (2023)

Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension
por: Al-Qazazi, Ruaa, et al.
Publicado: (2022)

Pulmonary hypertension and chronic lung disease: where are we headed?
por: Elia, Davide, et al.
Publicado: (2019)

Revisiting the Role for HIF Stabilizers in Bronchopulmonary Dysplasia
por: Boucherat, Olivier, et al.
Publicado: (2020)

Reverse Reaction of Nicotinamide Nucleotide Transhydrogenase Promotes ROS Production and Contributes to Right Ventricular Failure
por: Lemay, Sarah-Eve, et al.
Publicado: (2022)

Pulmonary arterial hypertension
por: Montani, David, et al.
Publicado: (2013)

Endothelial dysfunction in pulmonary arterial hypertension: an evolving landscape (2017 Grover Conference Series)
por: Ranchoux, Benoît, et al.
Publicado: (2017)

Potts anastomosis in children with severe pulmonary arterial hypertension and atrial septal defect
por: Capel, Alice, et al.
Publicado: (2020)

Near-fatal haemoptysis as presentation of a giant intralobar pulmonary sequestration
por: Ferland, Nancy, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_909f78s4t0vtlu8n1aibpjgi9h